Equities

ModivCare Inc

ModivCare Inc

Actions
  • Price (EUR)16.00
  • Today's Change1.20 / 8.11%
  • Shares traded370.00
  • 1 Year change-57.67%
  • Beta--
Data delayed at least 15 minutes, as of Nov 13 2024 14:56 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Modivcare Inc. is a technology-enabled healthcare services company that provides a suite of integrated supportive care solutions for public and private payors and their members. It is a provider of non-emergency medical transportation (NEMT), personal care services (PCS), and remote patient monitoring (RPM) solutions. Its segments include NEMT, PCS, RPM, and Corporate and Other. The NEMT segment provides non-emergency medical transportation services throughout the country. The PCS segment provides non-medical personal care and home health services. Additionally, services provided in its PCS segment include placements of non-medical personal care assistants, home health aides and nurses primarily to Medicaid patient populations in need of care monitoring and assistance performing daily living activities in the home setting. RPM segment provides remote patient monitoring solutions, which include the monitoring of personal emergency response systems (PERS), vitals monitoring, and others.

  • Revenue in USD (TTM)2.79bn
  • Net income in USD-183.04m
  • Incorporated1996
  • Employees21.20k
  • Location
    ModivCare Inc6900 LAYTON AVENUE, 12TH FLOORDENVER 80237United StatesUSA
  • Phone+1 (303) 728-7030
  • Fax+1 (520) 747-6605
  • Websitehttps://modivcare.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.